# Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome

> **NCT01361087** · PHASE3 · WITHDRAWN · sponsor: **Ann & Robert H Lurie Children's Hospital of Chicago**

## Conditions studied

- Marfan Syndrome

## Interventions

- **OTHER:** Blood draw

## Key facts

- **NCT ID:** NCT01361087
- **Lead sponsor:** Ann & Robert H Lurie Children's Hospital of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-04
- **Primary completion:** 2014-12
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No outside recruitment of subjects from Main Atenolol VS Losartan NIH study
- **Last updated:** 2016-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01361087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01361087, "Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01361087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*